The use of stable isotope labeling and liquid chromatography/tandem mass spectrometry techniques to study the pharmacokinetics and bioavailability of the antimigraine drug, MK-0462 (rizatriptan) in dogs

Rapid Communications in Mass Spectrometry

Volumn 10, Issue 9, 1996, Pages 1033-1037

  Barrish, A ^a   Olah, T V ^a   Gatto, G J ^a   Michel, K B ^a   Dobrinska, M R ^a   Gilbert, J D ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; ISOTOPES; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

ANTIMIGRAINE; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; MS DETECTION; SIMULTANEOUS DETERMINATIONS; STABLE ISOTOPES; STABLE-ISOTOPE LABELING; TANDEM MASS SPECTROMETRY; TANDEM MASS SPECTROMETRY TECHNIQUES; TANDEM-MASS SPECTROMETRY;

PHARMACOKINETICS;

EID: 0029760078     PISSN: 09514198     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0231(19960715)10:9<1033::AID-RCM616>3.0.CO;2-4     Document Type: Article

References (14)

1. R. L. Wolen and W. A. Garland, in Synthesis and Applications of Isotopically-labelled Compounds (eds, T. A. Baillie and J. R. Jones), pp. 147-156. Elsevier, Amsterdam, 1988.
2. G. Mikus, C. Fischer, B. Heuer, C. Langen and M. Eichelbaum, Br. J. Clin. Pharmac. 24, 561-569 (1987).
3. Y. Kasuya, K. Mamada, S. Baba and M. Matsukura, J. Pharm. Sci. 74, 503-507 (1985).
4. W. J. A. Vandenheuvel, J. R. Carlin and R. W. Walker, J. Chromatogr. Sci. 21, 119-124 (1983).
5. H. A. Heck, S. E. Buttrill, N. W. Flynn, R. L. Dyer, M. Anbar, T. Cairns, S. Dighe and B. E. Cabana, J. Pharmacokinet. Biopharm. 7, 233-248 (1979).
6. R. E. Gammans, A. V. MacKenthun and J. W. Russell, Br. J. Clin. Pharmac. 18, 431-437 (1984).
7. J. D. Gilbert, E. L. Hand, A. S. Yuan, T. V. Olah and T. R. Covey, Biol. Mass Spectrom. 21, 63-68 (1992).
8. J. D. Gilbert, T. V. Olah and D. A. McLoughlin, in Biological and Biotechnological Applications of ESI-MS (ed. A. P. Snyder), ACS Symposia Series, 619, 330-350 (1996).
9. C. Chen, D. R. Lieberman, R. D. Larsen, R. A. Reamer, T. R. Verhoeven and P. J. Reider, Tetrahedron Lett. 35, 6981-6984 (1994).
10. D. A. McLoughlin, T. V. Olah, J. D. Ellis, R. A. Halpin and J. D. Gilbert, J. Chromatogr. 726, 115-124 (1996).
11. M. J. Avery, D. Y. Mitchell, F. C. Falkner and H. G. Fouda, Biol. Mass Spectrom. 21, 353-357 (1992).
12. H. Cheng, W. J. Polvino, D. Sciberras, L. Yogendran, K. A. Cherchio, K. Christie, T. V. Olah, D. McLoughlin, I. James and J. D. Rogers, Biopharm. Drug Dispos. 17, 17-24 (1996).
13. R. A. Halpin, unpublished observations.
14. T. N. Tozer and G. M. Rubin, in Pharmacokinetics-Regulatory, Industrial. Academic Perspectives (eds, P. G. Welling and F. L. S. Tse), ch. 12, Marcel Dekker, Inc., New York, 1988.